Life Science Playground: IP Roadblocks Faced by Biotech & Pharma Entities
October 18, 2021
Life Science Playground
Key IP issues pharmaceutical and biotech Entities face as they develop their business strategies
IP issues are among the most challenging and complex considerations that life science and biotech start-ups may face. Recent years have demonstrated record patent filings, assertions of intellectual property rights, and licensing deals created during this exciting and innovative time for the life sciences industry.
We aim to explore the costs, benefit, and role patents and IP may play in biotech start-up development. And, in addition, we will provide guidance on building an IP strategy that supports long-term business objectives and growth.
Come to our playground and mix and mingle with other entrepreneurs and thought leaders in the life sciences sector.